LISATA THERAPEUTICS, INC. (LSTA) Operating cash flow 2015–2024
LISATA THERAPEUTICS, INC. (LSTA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$15.9MFY2024 · since FY2015: -$23.7M → -$15.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$15.9M | +17.6% |
| FY2023 | -$19.4M | +3.4% |
| FY2022 | -$20.0M | +5.4% |
| FY2021 | -$21.2M | +4.8% |
| FY2020 | -$22.2M | -152.1% |
| FY2019 | -$8.8M | +53.3% |
| FY2018 | -$18.9M | +5.5% |
| FY2017 | -$20.0M | +4.3% |
| FY2016 | -$20.9M | +11.8% |
| FY2015 | -$23.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice